A recent deal to "bundle" the purchase of 100 Stryker Nuclear Biological Chemical Reconnaissance Vehicles with 292 double-V hull variants already under contract will save the Army nearly $50 million, according to an acquisition decision memorandum obtained by InsideDefense.com. Both vehicles are built by General Dynamics Land Systems. The ADM, signed Dec. 15 by Frank Kendall, the acting Pentagon acquisition executive, also clears the way for full-rate production of the NBCRV, which was in development. "The FRP decision will...
